Liver fibrosis model
Authors:
Philip M E. Probert
Mohammad R. Ebrahimkhani
Fiona Oakley
Jelena Mann
Alastair D. Burt
Derek A. Mann
Matthew C. Wright
Publication:
Toxicology Research 3, 98-109 doi: 10.1039/C3TX50069A
Publish Date:
28 August 2013
Background
Bile duct ligation (BDL), a common model for hepatic periportal fibrosis, is a surgical procedure involving the double ligation of the common bile duct. This procedure presents several challenges, as it is an irreversible, severe procedure, in which the severity of the induced injury cannot be modulated, resulting in high mortality of animals.
Summary
Methapyrilene was used as a sedative and anti-histamine until the late 70s when it was found to promote liver damage in rats. In this paper, chronic administration of methapyrilene is proposed as an alternative model to bile duct ligation. This refined model does not require surgery and is less severe as it allows for modulating the degree of injury, is reversible, and results in minimal mortality.
Key Actions
- Always review the literature to identify refined protocols, models, or non-animal alternatives.
- Seek to avoid using BDL and use more refined models wherever possible.
Further questions
Authors
Philip M. E. Probert - Newcastle University
Mohammad R. Ebrahimkhani - New York University School of Medicine
Fiona Oakley - Newcastle University
Jelena Mann - Newcastle University
Alastair D. Burt - Newcastle University
Derek A. Mann - Newcastle University
Matthew C. Wright - Newcastle University
